TROW Q1 2026 Earnings Strong EPS Beat Amid Quiet Markets Telomir Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss as Revenue Remains Absent PFIS Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction Harvard Endowment Faces Private Equity Hangover as Succession Looms for Narvekar Duolingo Q1 2026 Earnings EPS Beats Estimates by 164 Shares Edge Lower Tvardi Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as pipeline advances